Evolutionary Genomics IncOver The Counter Market:FNAM
- LAST PRICE0.0008
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0008
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evolutionary Genomics Inc | 5.3K | 0.0x | --- |
Baseline Productions Inc | 370.0 | 0.0x | --- |
PZ Wind Down Inc | 10.0 | 0.0x | --- |
FluoroPharma Medical Inc | 3.4K | 0.0x | --- |
Regenicin Inc | 15.4K | 0.0x | --- |
Psycheceutical Bioscience Inc | 27.6K | 0.0x | --- |
Company Information
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.
Contact Information
- Headquarters
- 4220 Morningstar DriveCASTLE ROCK, CO, United States 80108
- Phone
- 720-900-8666
- Fax
- 303-862-3225
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.3K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 6.7M |
Evolutionary Genomics Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.35 |
Book Value | $-0.24 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
